Neuen, B. L., Oshima, M., Perkovic, V., Agarwal, R., Arnott, C., Bakris, G., . . . Heerspink, H. J. L. (2021). Effects of canagliflozin on serum potassium in people with diabetes and chronic kidney disease: The CREDENCE trial.
Citación estilo ChicagoNeuen, Brendon L., et al. Effects of Canagliflozin On Serum Potassium in People With Diabetes and Chronic Kidney Disease: The CREDENCE Trial. 2021.
Cita MLANeuen, Brendon L., et al. Effects of Canagliflozin On Serum Potassium in People With Diabetes and Chronic Kidney Disease: The CREDENCE Trial. 2021.
Precaución: Estas citas no son 100% exactas.